Post Chronicle, June 27, 2007 GALVESTON - U.S. scientists have determined the use of certain drugs to fight cancer-related bone problems might increase the risk of disease or infection. University of Texas Medical Branch researchers discovered treatment with intravenous bisphosphonates -- drugs used to reduce harm done to bones by cancer or cancer therapy -- increases the risk of jaw or facial bone disease or infection. Using National Cancer Institute data, UTMB investigators compared more than 14,000 cancer patients treated with intravenous bisphosphonates with nearly 27,000 cancer patients not receiving the drugs. Read more. . .